Future Science Group

Biomarkers in Medicine accepted in MEDLINE

BMM cover

Biomarkers in Medicine accepted for coverage in MEDLINE®

Future Medicine Ltd announced today that its journal Biomarkers in Medicine (ISSN 1752-0363) has been selected for coverage in MEDLINE®. Maintained by the U.S. National Library of Medicine, MEDLINE® (Medical Literature Analysis and Retrieval System Online) is a premier bibliographic database containing approximately 13 million references to journal articles in life sciences.

Biomarkers in Medicine is published on a bimonthly basis in print and online formats on a rapid publication basis, with articles subject to peer review by three independent assessors. The journal has an international expert authorship and offers commentary and analysis on the advances in our understanding of biomarkers and their potential and actual applications in medicine. The journal facilitates translation of our research knowledge into the clinic to increase the effectiveness of medical practice.

Coverage of the journal is directed by two Senior Editors and an extensive international advisory panel. The two Senior Editors are Prof. Scott Waldman, Chair of the Department of Pharmacology and Experimental Therapeutics for Thomas Jefferson University in Philadelphia, PA, USA and Prof. Andre Terzic of the Mayo Clinic, Rochester, MN, USA.

The scientific rationale and regulatory acceptance for biomarkers in medicine and in drug development has become more fully established, and Biomarkers in Medicine provides the platform for all players in this increasingly vital area to communicate and debate all issues relating to the potential utility and applications. Each issue includes a diversity of content to provide rounded coverage for the research professional. Articles include Guest Editorials, Interviews, Reviews, Research Articles, Perspectives, Research Highlights, Special Reports, Case Reports, Conference Reports and Company Profiles. Review coverage is divided into themed sections according to area of therapeutic utility with some issues including themeds sections on an area of topical interest. The audience for Biomarkers in Medicine includes academic and industrial researchers, clinicians, pathologists, clinical chemists and regulatory professionals. 

Access to Biomarkers in Medicine is also currently available via free 30-day trial. To apply for your free trial please email info@futuremedicine.com quoting reference BMM0310 to obtain password access.

PDF of the full press release attached below.